Skip to main content
NIH
Forecasted

RFA-RM-26-001

NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)

Summary

AI-generated

NIH Director's Pioneer Award

Research Focus

The NIH Director's Pioneer Award funds exceptionally creative individual scientists pursuing bold, highly innovative research with potential for major impact across broad biomedical domains. The program prioritizes proposals that represent substantially different scientific directions from the applicant's existing work or the broader field. Research spanning basic science, translational research, systems biology, computational biology, and precision medicine is welcome—including work on disease mechanisms, therapeutic development, and innovative methodologies. The award targets interdisciplinary approaches that could reshape understanding or practice in their respective areas.

At a Glance

  • Who can apply: Individual scientists of exceptional creativity; applications in any biomedical sciences area welcome
  • Funding & project length: Not stated
  • Award mechanism: Pioneer Award (component of NIH High-Risk, High-Reward Research Program)
  • Key dates: Not stated
  • Best fit for: Researchers in biomedical sciences (basic, translational, computational) with bold, paradigm-shifting ideas substantially divergent from current work

Note: Specific funding amounts, project duration, and submission deadlines are not provided in this summary. Consult the full FOA and NIH Common Fund website for complete details.

Insights (5)

Exceptional creativity and bold innovation are non-negotiable competitive requirements

strategic fit

The Pioneer Award explicitly demands research that is 'substantially different' from the applicant's existing program and reflects 'exceptional creativity' with 'major impact' potential. This is not incremental funding for established research directions. Applicants must demonstrate a clear intellectual pivot—new methodologies, disease targets, or theoretical frameworks—backed by preliminary data or compelling conceptual foundations that justify the risk.

Pioneer Award favors established investigators with track record and credibility

career stage

While not formally restricted to senior investigators, the 'exceptional creativity' standard and requirement to diverge from prior work implicitly favor researchers with sufficient publication record and institutional standing to credibly propose high-risk directions. Early-stage investigators may face skepticism unless they can demonstrate prior accomplishments that justify confidence in their ability to execute a bold new direction.

Interdisciplinary and systems-level approaches align with NIGMS and Common Fund priorities

strategic fit

The enrichment keywords (systems biology, computational biology, precision medicine, translational research) and NIGMS stewardship suggest strong receptivity to research that bridges traditional disciplinary boundaries or integrates multiple biological scales. Applications leveraging novel computational, engineering, or cross-disciplinary methodologies to address fundamental biomedical questions will be competitive.

Highly selective mechanism with limited awards and broad scope creates intense competition

competition

The Pioneer Award is a flagship NIH program with typically 5–10 awards per cycle across all biomedical sciences. The open scope (any area within biomedical sciences) means competition spans the entire research enterprise. Success requires not just scientific excellence but a compelling narrative of transformative potential that distinguishes the proposal from hundreds of other high-quality submissions.

Preliminary data and feasibility are critical despite 'high-risk' framing

strategic fit

Although the program embraces risk, reviewers will expect evidence that the proposed direction is scientifically grounded and achievable. Vague or purely speculative proposals will not succeed. Applicants should present proof-of-concept data, preliminary results, or a rigorous theoretical framework that demonstrates the feasibility of the bold new direction while maintaining intellectual novelty.

Key Facts

Deadline

Posted

Thu, December 11, 2025

Award Range

$700,000 $700,000

Expected Awards

8

DP1
93.310
Grants.gov

Keywords

biomedical sciences
translational research
systems biology
computational biology
precision medicine
therapeutic development
innovative research methodologies
disease mechanisms
basic research
interdisciplinary research

Research Areas

NIH Institute
General Medical SciencesNIGMS
OpenAlex
Life SciencesD1Health SciencesD4
Fields
Biochemistry, Genetics & Molecular BiologyF13Immunology & MicrobiologyF24MedicineF27NeuroscienceF28Pharmacology, Toxicology & PharmaceuticsF30
Subfields
BiochemistryS1303BiotechnologyS1305Cell BiologyS1307GeneticsS1311Molecular BiologyS1312ImmunologyS2403Biochemistry (Medical)S2704EpidemiologyS2713Cellular & Molecular NeuroscienceS2804Drug DiscoveryS3002Pharmaceutical ScienceS3003PharmacologyS3004
Topics
Genomics and Phylogenetic StudiesT10015Protein Structure and DynamicsT10044Developmental Biology and Gene RegulationT10268Epigenetics and DNA MethylationT10269RNA and protein synthesis mechanismsT10521CRISPR and Genetic EngineeringT10878Bioinformatics and Genomic NetworksT10887Virology and Viral DiseasesT11135+3 more
MeSH
AnatomyADiseasesCChemicals & DrugsDAnalytical/Diagnostic/Therapeutic TechniquesEPsychiatry & PsychologyFPhenomena & ProcessesG
Disciplines & OccupationsH
Natural Science DisciplinesH01
Health CareN
Health Care EconomicsN03Health Services AdministrationN04
ANZSRC FoR
Biological Sciences31
Biochemistry & Cell Biology3101Bioinformatics & Computational Biology3102Microbiology3107
Biomedical & Clinical Sciences32
Clinical Sciences3202Immunology3204Medical Biochemistry & Metabolomics3205Medical Biotechnology3206Neurosciences3209
Chemical Sciences34
Medicinal & Biomolecular Chemistry3404
Information & Computing46
Artificial Intelligence4602Data Management & Data Science4605
Mathematical Sciences49

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About